- Home
- CLB vs INNV Comparison
CLB vs INNV Comparison
Compare CLB & INNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLB
- INNV
- Stock Information
- Founded
- CLB 1936
- INNV 2007
- Country
- CLB United States
- INNV United States
- Employees
- CLB N/A
- INNV N/A
- Industry
- CLB
- INNV Medical/Nursing Services
- Sector
- CLB
- INNV Health Care
- Exchange
- CLB Nasdaq
- INNV Nasdaq
- Market Cap
- CLB 482.5M
- INNV 485.4M
- IPO Year
- CLB 1995
- INNV 2021
- Fundamental
- Price
- CLB $12.49
- INNV $4.98
- Analyst Decision
- CLB Hold
- INNV Sell
- Analyst Count
- CLB 2
- INNV 2
- Target Price
- CLB $12.50
- INNV $5.00
- AVG Volume (30 Days)
- CLB 501.8K
- INNV 35.2K
- Earning Date
- CLB 10-22-2025
- INNV 09-09-2025
- Dividend Yield
- CLB 0.32%
- INNV N/A
- EPS Growth
- CLB 23.99
- INNV N/A
- EPS
- CLB 0.62
- INNV N/A
- Revenue
- CLB $517,378,000.00
- INNV $853,699,000.00
- Revenue This Year
- CLB N/A
- INNV $10.46
- Revenue Next Year
- CLB $2.23
- INNV $10.50
- P/E Ratio
- CLB $20.26
- INNV N/A
- Revenue Growth
- CLB 0.70
- INNV 11.76
- 52 Week Low
- CLB $9.72
- INNV $2.60
- 52 Week High
- CLB $21.83
- INNV $6.69
- Technical
- Relative Strength Index (RSI)
- CLB 58.33
- INNV 68.74
- Support Level
- CLB $12.33
- INNV $3.69
- Resistance Level
- CLB $12.82
- INNV $4.63
- Average True Range (ATR)
- CLB 0.52
- INNV 0.35
- MACD
- CLB 0.07
- INNV 0.14
- Stochastic Oscillator
- CLB 67.42
- INNV 81.63
About CLB Core Laboratories Inc.
Core Laboratories Inc provides reservoir description and production enhancement services for oil and gas exploration and production. It provides data and analytics to aid well operators in determining optimal methods for recovering, processing, and refining hydrocarbons from a well. It also manufactures the associated lab equipment for its services.
About INNV InnovAge Holding Corp.
InnovAge Holding Corp is a healthcare delivery platform by several participants focused on providing all-inclusive, capitated care to high-cost, dual-eligible seniors. Its patient-centered care delivery approach improves the quality of care while keeping them in their homes and reducing over-utilization of high-cost care settings such as hospitals and nursing homes. The company's segment includes PACE and others. It generates maximum revenue from the PACE segment.